Post Excision/Mohs Scar Laser Resurfacing
Completed · Not applicable
Conditions studied: Skin Cancer
In brief
The purpose of this study is to evaluate the potential benefits of treating a surgical scar post excision with an ablative fractionated CO2 laser with the goal of decreasing the appearance and size of the scar.
Key facts
- Study ID
- NCT02130297
- Run by
- Icahn School of Medicine at Mount Sinai
- People needed
- 30
- Starts
- 2014-05-01
- Expected to finish
- 2019-03-19
- Last updated by the study team
- 2021-04-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Must understand and voluntarily sign an informed consent form.
- Must be male or female and aged >18 years at the time of consent.
- Must be able to adhere to the study visit schedule and other protocol requirements.
- Patients undergoing skin excisions of the face/trunk/extremities.
You may not qualify if…
- Inability to provide voluntary informed consent
- Use of laser or light based treatments to affected areas in past year
- Fitzpatrick Skin types 3-5
- Surgical lesions located on the central chest
- History of keloid formation
- History of Accutane in the last six months
Where it is running
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.